Stockreport

Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]

Artiva Biotherapeutics, Inc.  (ARTV) 
PDF Artiva Biotherapeutics, Inc. Initial clinical response data for AlloNK ® in refractory rheumatoid arthritis (RA) expected in first half of 2026 U.S. Food and Drug A [Read more]